Augmenting Transgene Expression from Carcinoembryonic Antigen (CEA) Promoter via a GAL4 Gene Regulatory System

This publication has 14 references indexed in Scilit:

• A binary adenoviral vector system for expressing high levels of the proapoptotic gene bax
  Gene Therapy, 2000
• Evaluation of GAL4/TATA in Vivo
  Published by Elsevier ,1998
• A Packaging System for SV40 Vectors without Viral Coding Sequences
  Analytical Biochemistry, 1997
• Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector
  Nature Medicine, 1997
• Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter.
  Journal of Clinical Investigation, 1995
• Transcriptional Regulatory Sequences of Carcinoembryonic Antigen: Identification and Use with Cytosine Deaminase for Tumor-Specific Gene Therapy
  Human Gene Therapy, 1995
• Carcinoembryonic antigen gene family: Molecular biology and clinical perspectives
  Journal of Clinical Laboratory Analysis, 1991
• Cloning of the complete gene for carcinoembryonic antigen: analysis of its promoter indicates a region conveying cell type-specific expression.
  Molecular and Cellular Biology, 1990
• Molecular cloning of a gene for a member of carcinoembryonic antigen (CEA) gene family; Signal peptide and N-terminal domain sequences of nonspecific crossreacting antigen (NCA)
  Biochemical and Biophysical Research Communications, 1987
• Sequence analysis of carcinoembryonic antigen: identification of glycosylation sites and homology with the immunoglobulin supergene family.
  Proceedings of the National Academy of Sciences, 1987